Selected research
Market Outlook & Growth Opportunities
Global NAD+ IV Therapy Market Outlook and Growth Opportunities 2026
Market perspective
The global NAD+ IV Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NAD+ IV Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the NAD+ IV Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the NAD+ IV Therapy market include Toronto Functional Medicine Centre, Thedripclub, The Wellness Lab, Seaside Skin Care, Rocky Mountain Ivmedics, Reset IV, Premiumhealth, Nadclinic and Mobileivmedics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global NAD+ IV Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of NAD+ IV Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents NAD+ IV Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global NAD+ IV Therapy market.
NAD+ IV Therapy Segment by Company
Toronto Functional Medicine Centre
Thedripclub
The Wellness Lab
Seaside Skin Care
Rocky Mountain Ivmedics
Reset IV
Premiumhealth
Nadclinic
Mobileivmedics
LIVV Natural
IV Boost UK
Hydrate IV Bar
Effect Doctors
Conciergemdla
BioReset Medical
Azivmedics
NAD+ IV Therapy Segment by Type
NAD+ Mixed Vitamin Injections
Pure NAD+ Injection
NAD+ IV Therapy Segment by Application
Clinic
Hospital
Residential
NAD+ IV Therapy Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global NAD+ IV Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the NAD+ IV Therapy key companies, revenue, market share, and recent developments.
3. To split the NAD+ IV Therapy breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions NAD+ IV Therapy market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify NAD+ IV Therapy significant trends, drivers, influence factors in global and regions.
6. To analyze NAD+ IV Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ IV Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ IV Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ IV Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NAD+ IV Therapy industry.
Chapter 3: Detailed analysis of NAD+ IV Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of NAD+ IV Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of NAD+ IV Therapy in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
List of Tables
Table 1. NAD+ IV Therapy Industry Trends
Table 2. NAD+ IV Therapy Industry Drivers
Table 3. NAD+ IV Therapy Industry Opportunities and Challenges
Table 4. NAD+ IV Therapy Industry Restraints
Table 5. Global NAD+ IV Therapy Revenue by Company (US$ Million) & (2021-2026)
Table 6. Global NAD+ IV Therapy Revenue Share by Company (2021-2026)
Table 7. Global NAD+ IV Therapy Company Ranking, (2024-2026) & (US$ Million)
Table 8. Global NAD+ IV Therapy Key Company Manufacturing Base & Headquarters
Table 9. Global NAD+ IV Therapy Company, Product Type & Application
Table 10. Global NAD+ IV Therapy Company Establishment Date
Table 11. Global Company Market Concentration Ratio (CR5 and HHI)
Table 12. Global NAD+ IV Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025)
Table 13. Mergers & Acquisitions, Expansion
Table 14. Significant Companies of NAD+ Mixed Vitamin Injections
Table 15. Significant Companies of Pure NAD+ Injection
Table 16. Global NAD+ IV Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million)
Table 17. Global NAD+ IV Therapy Sales Value by Type (2021-2026) & (US$ Million)
Table 18. Global NAD+ IV Therapy Sales Value by Type (2027-2032) & (US$ Million)
Table 19. Global NAD+ IV Therapy Sales Value Share by Type (2021-2026)
Table 20. Global NAD+ IV Therapy Sales Value Share by Type (2027-2032)
Table 21. Significant Companies of Clinic
Table 22. Significant Companies of Hospital
Table 23. Significant Companies of Residential
Table 24. Global NAD+ IV Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million)
Table 25. Global NAD+ IV Therapy Sales Value by Application (2021-2026) & (US$ Million)
Table 26. Global NAD+ IV Therapy Sales Value by Application (2027-2032) & (US$ Million)
Table 27. Global NAD+ IV Therapy Sales Value Share by Application (2021-2026)
Table 28. Global NAD+ IV Therapy Sales Value Share by Application (2027-2032)
Table 29. Global NAD+ IV Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 30. Global NAD+ IV Therapy Sales Value by Region (2021-2026) & (US$ Million)
Table 31. Global NAD+ IV Therapy Sales Value Share by Region (2021-2026)
Table 32. Global NAD+ IV Therapy Sales Value by Region (2027-2032) & (US$ Million)
Table 33. Global NAD+ IV Therapy Sales Value Share by Region (2027-2032)
Table 34. Global NAD+ IV Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 35. Global NAD+ IV Therapy Sales Value by Country (2021-2026) & (US$ Million)
Table 36. Global NAD+ IV Therapy Sales Value Market Share by Country (2021-2026)
Table 37. Global NAD+ IV Therapy Sales Value by Country (2027-2032) & (US$ Million)
Table 38. Global NAD+ IV Therapy Sales Value Market Share by Country (2027-2032)
Table 39. Toronto Functional Medicine Centre Company Information
Table 40. Toronto Functional Medicine Centre Business Overview
Table 41. Toronto Functional Medicine Centre NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 42. Toronto Functional Medicine Centre NAD+ IV Therapy Product Portfolio
Table 43. Toronto Functional Medicine Centre Recent Development
Table 44. Thedripclub Company Information
Table 45. Thedripclub Business Overview
Table 46. Thedripclub NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 47. Thedripclub NAD+ IV Therapy Product Portfolio
Table 48. Thedripclub Recent Development
Table 49. The Wellness Lab Company Information
Table 50. The Wellness Lab Business Overview
Table 51. The Wellness Lab NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 52. The Wellness Lab NAD+ IV Therapy Product Portfolio
Table 53. The Wellness Lab Recent Development
Table 54. Seaside Skin Care Company Information
Table 55. Seaside Skin Care Business Overview
Table 56. Seaside Skin Care NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 57. Seaside Skin Care NAD+ IV Therapy Product Portfolio
Table 58. Seaside Skin Care Recent Development
Table 59. Rocky Mountain Ivmedics Company Information
Table 60. Rocky Mountain Ivmedics Business Overview
Table 61. Rocky Mountain Ivmedics NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 62. Rocky Mountain Ivmedics NAD+ IV Therapy Product Portfolio
Table 63. Rocky Mountain Ivmedics Recent Development
Table 64. Reset IV Company Information
Table 65. Reset IV Business Overview
Table 66. Reset IV NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 67. Reset IV NAD+ IV Therapy Product Portfolio
Table 68. Reset IV Recent Development
Table 69. Premiumhealth Company Information
Table 70. Premiumhealth Business Overview
Table 71. Premiumhealth NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 72. Premiumhealth NAD+ IV Therapy Product Portfolio
Table 73. Premiumhealth Recent Development
Table 74. Nadclinic Company Information
Table 75. Nadclinic Business Overview
Table 76. Nadclinic NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 77. Nadclinic NAD+ IV Therapy Product Portfolio
Table 78. Nadclinic Recent Development
Table 79. Mobileivmedics Company Information
Table 80. Mobileivmedics Business Overview
Table 81. Mobileivmedics NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 82. Mobileivmedics NAD+ IV Therapy Product Portfolio
Table 83. Mobileivmedics Recent Development
Table 84. LIVV Natural Company Information
Table 85. LIVV Natural Business Overview
Table 86. LIVV Natural NAD+ IV Therapy Revenue (US$ Million) and Gross Margin (2021-2026)
Table 87. LIVV Natural NAD+ IV Therapy Product Portfolio
Table 88. LIVV Natural Recent Development
Table 89. IV Boost UK Company Information
Table 90. IV Boost UK Business Overview
Table 91. IV Boost UK NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. IV Boost UK NAD+ IV Therapy Product Portfolio
Table 93. IV Boost UK Recent Development
Table 94. Hydrate IV Bar Company Information
Table 95. Hydrate IV Bar Business Overview
Table 96. Hydrate IV Bar NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Hydrate IV Bar NAD+ IV Therapy Product Portfolio
Table 98. Hydrate IV Bar Recent Development
Table 99. Effect Doctors Company Information
Table 100. Effect Doctors Business Overview
Table 101. Effect Doctors NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Effect Doctors NAD+ IV Therapy Product Portfolio
Table 103. Effect Doctors Recent Development
Table 104. Conciergemdla Company Information
Table 105. Conciergemdla Business Overview
Table 106. Conciergemdla NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Conciergemdla NAD+ IV Therapy Product Portfolio
Table 108. Conciergemdla Recent Development
Table 109. BioReset Medical Company Information
Table 110. BioReset Medical Business Overview
Table 111. BioReset Medical NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. BioReset Medical NAD+ IV Therapy Product Portfolio
Table 113. BioReset Medical Recent Development
Table 114. Azivmedics Company Information
Table 115. Azivmedics Business Overview
Table 116. Azivmedics NAD+ IV Therapy Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Azivmedics NAD+ IV Therapy Product Portfolio
Table 118. Azivmedics Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Authors List of This Report
Table 121. Secondary Sources
Table 122. Primary Sources
List of Figures
Figure 1. NAD+ IV Therapy Product Image
Figure 2. Global NAD+ IV Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global NAD+ IV Therapy Market Size (2021-2032) & (US$ Million)
Figure 4. Global NAD+ IV Therapy Company Revenue Ranking in 2025 (US$ Million)
Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million)
Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 7. NAD+ Mixed Vitamin Injections Image
Figure 8. Pure NAD+ Injection Image
Figure 9. Global NAD+ IV Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global NAD+ IV Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 11. Global NAD+ IV Therapy Sales Value Share by Type (2021-2032)
Figure 12. Clinic Image
Figure 13. Hospital Image
Figure 14. Residential Image
Figure 15. Global NAD+ IV Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 16. Global NAD+ IV Therapy Sales Value Share 2021 VS 2025 VS 2032
Figure 17. Global NAD+ IV Therapy Sales Value Share by Application (2021-2032)
Figure 18. Global NAD+ IV Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 19. Global NAD+ IV Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032
Figure 20. North America NAD+ IV Therapy Sales Value (2021-2032) & (US$ Million)
Figure 21. North America NAD+ IV Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 22. Europe NAD+ IV Therapy Sales Value (2021-2032) & (US$ Million)
Figure 23. Europe NAD+ IV Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 24. Asia-Pacific NAD+ IV Therapy Sales Value (2021-2032) & (US$ Million)
Figure 25. Asia-Pacific NAD+ IV Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 26. South America NAD+ IV Therapy Sales Value (2021-2032) & (US$ Million)
Figure 27. South America NAD+ IV Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 28. Middle East & Africa NAD+ IV Therapy Sales Value (2021-2032) & (US$ Million)
Figure 29. Middle East & Africa NAD+ IV Therapy Sales Value Share by Country (%), 2025 VS 2032
Figure 30. USA NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 31. USA NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 32. USA NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 33. Canada NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 34. Canada NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 35. Canada NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 36. Mexico NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 37. Mexico NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 38. Mexico NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 39. Germany NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 40. Germany NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 41. Germany NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 42. France NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 43. France NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 44. France NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 45. U.K. NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 46. U.K. NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 47. U.K. NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 48. Italy NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 49. Italy NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 50. Italy NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 51. Spain NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 52. Spain NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 53. Spain NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 54. Russia NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 55. Russia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 56. Russia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 57. Netherlands NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 58. Netherlands NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 59. Netherlands NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 60. Nordic Countries NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 61. Nordic Countries NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 62. Nordic Countries NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 63. China NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 64. China NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 65. China NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 66. Japan NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 67. Japan NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 68. Japan NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 69. South Korea NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 70. South Korea NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 71. South Korea NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 72. India NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 73. India NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 74. India NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 75. Australia NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 76. Australia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 77. Australia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 78. Southeast Asia NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 79. Southeast Asia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 80. Southeast Asia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 81. Brazil NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 82. Brazil NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 83. Brazil NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 84. Argentina NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 85. Argentina NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 86. Argentina NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 87. Chile NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 88. Chile NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 89. Chile NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 90. Colombia NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 91. Colombia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 92. Colombia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 93. Peru NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 94. Peru NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 95. Peru NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 96. Saudi Arabia NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 97. Saudi Arabia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 98. Saudi Arabia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 99. Israel NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 100. Israel NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 101. Israel NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 102. UAE NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 103. UAE NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 104. UAE NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 105. Turkey NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 106. Turkey NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 107. Turkey NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 108. Iran NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 109. Iran NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 110. Iran NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 111. Egypt NAD+ IV Therapy Sales Value Growth Rate (2021-2032) & (US$ Million)
Figure 112. Egypt NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032 & (%)
Figure 113. Egypt NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032 & (%)
Figure 114. Years Considered
Figure 115. Research Process
Figure 116. Key Executives Interviewed
Scope & coverage.
Types
- NAD+ Mixed Vitamin Injections
- Pure NAD+ Injection
Applications
- Clinic
- Hospital
- Residential
Companies covered
- Toronto Functional Medicine Centre
- Thedripclub
- The Wellness Lab
- Seaside Skin Care
- Rocky Mountain Ivmedics
- Reset IV
- Premiumhealth
- Nadclinic
- Mobileivmedics
- LIVV Natural
- IV Boost UK
- Hydrate IV Bar
- Effect Doctors
- Conciergemdla
- BioReset Medical
- Azivmedics
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global NAD+ IV Therapy Market Size, 2021 VS 2025 VS 2032
- 1.3 Global NAD+ IV Therapy Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 NAD+ IV Therapy Market Dynamics
- 2.1 NAD+ IV Therapy Industry Trends
- 2.2 NAD+ IV Therapy Industry Drivers
- 2.3 NAD+ IV Therapy Industry Opportunities and Challenges
- 2.4 NAD+ IV Therapy Industry Restraints
3 NAD+ IV Therapy Market by Company
- 3.1 Global NAD+ IV Therapy Company Revenue Ranking in 2025
- 3.2 Global NAD+ IV Therapy Revenue by Company (2021-2026)
- 3.3 Global NAD+ IV Therapy Company Ranking (2024-2026)
- 3.4 Global NAD+ IV Therapy Company Manufacturing Base and Headquarters
- 3.5 Global NAD+ IV Therapy Company Product Type and Application
- 3.6 Global NAD+ IV Therapy Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global NAD+ IV Therapy Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 NAD+ IV Therapy Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 NAD+ IV Therapy Market by Type
- 4.1 NAD+ IV Therapy Type Introduction
- 4.1.1 NAD+ Mixed Vitamin Injections
- 4.1.2 Pure NAD+ Injection
- 4.2 Global NAD+ IV Therapy Sales Value by Type
- 4.2.1 Global NAD+ IV Therapy Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global NAD+ IV Therapy Sales Value by Type (2021-2032)
- 4.2.3 Global NAD+ IV Therapy Sales Value Share by Type (2021-2032)
5 NAD+ IV Therapy Market by Application
- 5.1 NAD+ IV Therapy Application Introduction
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Residential
- 5.2 Global NAD+ IV Therapy Sales Value by Application
- 5.2.1 Global NAD+ IV Therapy Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global NAD+ IV Therapy Sales Value by Application (2021-2032)
- 5.2.3 Global NAD+ IV Therapy Sales Value Share by Application (2021-2032)
6 NAD+ IV Therapy Regional Value Analysis
- 6.1 Global NAD+ IV Therapy Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global NAD+ IV Therapy Sales Value by Region (2021-2032)
- 6.2.1 Global NAD+ IV Therapy Sales Value by Region: 2021-2026
- 6.2.2 Global NAD+ IV Therapy Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America NAD+ IV Therapy Sales Value (2021-2032)
- 6.3.2 North America NAD+ IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe NAD+ IV Therapy Sales Value (2021-2032)
- 6.4.2 Europe NAD+ IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific NAD+ IV Therapy Sales Value (2021-2032)
- 6.5.2 Asia-Pacific NAD+ IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America NAD+ IV Therapy Sales Value (2021-2032)
- 6.6.2 South America NAD+ IV Therapy Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa NAD+ IV Therapy Sales Value (2021-2032)
- 6.7.2 Middle East & Africa NAD+ IV Therapy Sales Value Share by Country, 2025 VS 2032
7 NAD+ IV Therapy Country-level Value Analysis
- 7.1 Global NAD+ IV Therapy Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global NAD+ IV Therapy Sales Value by Country (2021-2032)
- 7.2.1 Global NAD+ IV Therapy Sales Value by Country (2021-2026)
- 7.2.2 Global NAD+ IV Therapy Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.3.2 USA NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.7.2 France NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.14.2 China NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.17.2 India NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt NAD+ IV Therapy Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt NAD+ IV Therapy Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt NAD+ IV Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Toronto Functional Medicine Centre
- 8.1.1 Toronto Functional Medicine Centre Company Information
- 8.1.2 Toronto Functional Medicine Centre Business Overview
- 8.1.3 Toronto Functional Medicine Centre NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.1.4 Toronto Functional Medicine Centre NAD+ IV Therapy Product Portfolio
- 8.1.5 Toronto Functional Medicine Centre Recent Developments
- 8.2 Thedripclub
- 8.2.1 Thedripclub Company Information
- 8.2.2 Thedripclub Business Overview
- 8.2.3 Thedripclub NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.2.4 Thedripclub NAD+ IV Therapy Product Portfolio
- 8.2.5 Thedripclub Recent Developments
- 8.3 The Wellness Lab
- 8.3.1 The Wellness Lab Company Information
- 8.3.2 The Wellness Lab Business Overview
- 8.3.3 The Wellness Lab NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.3.4 The Wellness Lab NAD+ IV Therapy Product Portfolio
- 8.3.5 The Wellness Lab Recent Developments
- 8.4 Seaside Skin Care
- 8.4.1 Seaside Skin Care Company Information
- 8.4.2 Seaside Skin Care Business Overview
- 8.4.3 Seaside Skin Care NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.4.4 Seaside Skin Care NAD+ IV Therapy Product Portfolio
- 8.4.5 Seaside Skin Care Recent Developments
- 8.5 Rocky Mountain Ivmedics
- 8.5.1 Rocky Mountain Ivmedics Company Information
- 8.5.2 Rocky Mountain Ivmedics Business Overview
- 8.5.3 Rocky Mountain Ivmedics NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.5.4 Rocky Mountain Ivmedics NAD+ IV Therapy Product Portfolio
- 8.5.5 Rocky Mountain Ivmedics Recent Developments
- 8.6 Reset IV
- 8.6.1 Reset IV Company Information
- 8.6.2 Reset IV Business Overview
- 8.6.3 Reset IV NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.6.4 Reset IV NAD+ IV Therapy Product Portfolio
- 8.6.5 Reset IV Recent Developments
- 8.7 Premiumhealth
- 8.7.1 Premiumhealth Company Information
- 8.7.2 Premiumhealth Business Overview
- 8.7.3 Premiumhealth NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.7.4 Premiumhealth NAD+ IV Therapy Product Portfolio
- 8.7.5 Premiumhealth Recent Developments
- 8.8 Nadclinic
- 8.8.1 Nadclinic Company Information
- 8.8.2 Nadclinic Business Overview
- 8.8.3 Nadclinic NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.8.4 Nadclinic NAD+ IV Therapy Product Portfolio
- 8.8.5 Nadclinic Recent Developments
- 8.9 Mobileivmedics
- 8.9.1 Mobileivmedics Company Information
- 8.9.2 Mobileivmedics Business Overview
- 8.9.3 Mobileivmedics NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.9.4 Mobileivmedics NAD+ IV Therapy Product Portfolio
- 8.9.5 Mobileivmedics Recent Developments
- 8.10 LIVV Natural
- 8.10.1 LIVV Natural Company Information
- 8.10.2 LIVV Natural Business Overview
- 8.10.3 LIVV Natural NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.10.4 LIVV Natural NAD+ IV Therapy Product Portfolio
- 8.10.5 LIVV Natural Recent Developments
- 8.11 IV Boost UK
- 8.11.1 IV Boost UK Company Information
- 8.11.2 IV Boost UK Business Overview
- 8.11.3 IV Boost UK NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.11.4 IV Boost UK NAD+ IV Therapy Product Portfolio
- 8.11.5 IV Boost UK Recent Developments
- 8.12 Hydrate IV Bar
- 8.12.1 Hydrate IV Bar Company Information
- 8.12.2 Hydrate IV Bar Business Overview
- 8.12.3 Hydrate IV Bar NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.12.4 Hydrate IV Bar NAD+ IV Therapy Product Portfolio
- 8.12.5 Hydrate IV Bar Recent Developments
- 8.13 Effect Doctors
- 8.13.1 Effect Doctors Company Information
- 8.13.2 Effect Doctors Business Overview
- 8.13.3 Effect Doctors NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.13.4 Effect Doctors NAD+ IV Therapy Product Portfolio
- 8.13.5 Effect Doctors Recent Developments
- 8.14 Conciergemdla
- 8.14.1 Conciergemdla Company Information
- 8.14.2 Conciergemdla Business Overview
- 8.14.3 Conciergemdla NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.14.4 Conciergemdla NAD+ IV Therapy Product Portfolio
- 8.14.5 Conciergemdla Recent Developments
- 8.15 BioReset Medical
- 8.15.1 BioReset Medical Company Information
- 8.15.2 BioReset Medical Business Overview
- 8.15.3 BioReset Medical NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.15.4 BioReset Medical NAD+ IV Therapy Product Portfolio
- 8.15.5 BioReset Medical Recent Developments
- 8.16 Azivmedics
- 8.16.1 Azivmedics Company Information
- 8.16.2 Azivmedics Business Overview
- 8.16.3 Azivmedics NAD+ IV Therapy Revenue and Gross Margin (2021-2026)
- 8.16.4 Azivmedics NAD+ IV Therapy Product Portfolio
- 8.16.5 Azivmedics Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$4,250USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst